#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Adenocarcinoma gastric Congenital cystic kidney disease Heart disease congenital Hyperinsulinism Medullary thyroid cancer Systemic scleroderma Pulmonary fibrosis Demyelination Myxofibrosarcoma Progressive supranuclear palsy Pelizaeus-Merzbacher disease Acquired ATTR amyloidosis Retinopathy proliferative Antisynthetase syndrome Polycystic liver disease More trials…

    Learn about Rare Diseases

    Angelman’s syndrome – Trials in Disease Medulloblastoma recurrent – Life with Disease Adrenogenital syndrome – Diagnostics Activated PI3 kinase delta syndrome – Life with Disease Retinitis pigmentosa – Life with Disease Paroxysmal nocturnal haemoglobinuria – Basic Information Alveolar rhabdomyosarcoma – Trials in Disease Osteosarcoma metastatic – Life with Disease Hepatic angiosarcoma – Trials in Disease Methylmalonic acidaemia – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    GUAIACOL Axicabtagene Ciloleucel Almagate Difelikefalin Cls12311 Gns561 Florquinitau (18F) Glenzocimab Fludarabine Phosphate Ph. Eur. Leflunomide Ivosidenib Tamibarotene Ketamine Nms-03592088 Isosorbide Dinitrate Methoxyflurane Dexamfetamine Sulfate Abt-494 Valproate Semisodium Afamelanotide More therapies…

    Learn about Your Condition

    Becker's muscular dystrophy Frostbite Urinary incontinence Hairy cell leukaemia recurrent Allergic respiratory disease Thyroidectomy Vascular dementia Elderly Head injury Pruritus Hereditary angioedema Aortic stenosis Atrial flutter Tardive dyskinesia Rectal cancer recurrent More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Neoplasm malignant

  • Study on the Long-term Safety and Efficacy of Pembrolizumab and Lenvatinib for Patients with Advanced Tumors

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Favezelimab
    • Lenvatinib
    • Olaparib
    Austria Belgium Czechia Denmark Estonia Finland +15

  • Study of BMS-986340, Nivolumab, and Docetaxel for Adults with Advanced or Metastatic Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Neoplasm malignant
    Investigated Drugs:
    • Bms-986340
    • Docetaxel
    • Nivolumab
    Germany Italy Spain

  • Study on the Safety of GRWD5769 Alone and with Cemiplimab for Patients with Advanced Solid Tumors

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Grwd5769
    • Cemiplimab
    France Spain

  • Study of petosemtamab alone or with drug combination for patients with advanced colorectal cancer and other solid tumors

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Neoplasm malignant
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Petosemtamab
    • Calcium Folinate
    • Irinotecan
    Belgium France Italy The Netherlands Spain

  • Study on Preventing Opioid-Induced Constipation in Advanced Cancer Patients Using Magnesium Hydroxide and Macrogol 3350 Combination

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Neoplasm malignant
    Investigated Drugs:
    • Magnesium Hydroxide
    • Macrogol 3350
    • Sodium Hydrogen Carbonate
    The Netherlands

  • A Phase I/II Study of GVV858 Alone or in Drug Combination for Patients with Advanced Hormone Receptor‑Positive, HER2‑Negative Breast Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Neoplasm malignant
    • Hormone receptor positive HER2 negative breast cancer
    Investigated Drugs:
    • GVV858
    • Goserelin
    • Letrozole
    Czechia Denmark France Germany Italy Spain
Previous Page
1 … 6 7 8 9 10 … 21
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!